Kyverna Therapeutics
Harnessing the power of cell therapy in autoimmune disease.
160 employees · est. 2018 · Emeryville, United States
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Kyverna Therapeutics | TScan Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2018 |
| Headquarters | ||
| Headquarters | Emeryville, United States | Waltham, United States |
| Employees | ||
| Employees | 160 | 152 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | IPO | IPO |
| Total Funding | ||
| Total Funding | $489.00M | $662.60M |
| Funding Rounds | ||
| Funding Rounds | 6 | 9 |
| Services | ||
| Services | Development of CAR T-cell therapies for autoimmune diseases, Clinical trials management, Patient-centric therapeutic solutions, Next-generation cell therapy pipeline | Development of T-cell therapies, Genetically reprogramming T cells, Clinical trials for TCR-T therapy candidates, Anti-cancer TCR discovery |
| Target Customers | ||
| Target Customers | Patients with autoimmune diseases, Healthcare providers specializing in rheumatology and neurology, Clinical research organizations | Cancer patients, Patients with hematologic malignancies, Patients with solid tumors, Patients with autoimmune diseases |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Biopharmaceuticals, Autoimmune Diseases, CAR T-cell Therapy, CD19-targeting, Neuroimmunology, Stiff Person Syndrome, Generalized Myasthenia Gravis, Multiple Sclerosis, Rheumatoid Arthritis, T-cell Engineering, Synthetic Biology, Curative Treatments, B-cell-driven Diseases, Autologous Therapies | TCR-T Cell Therapy, T Cell Therapies, Biopharmaceutical, Hematologic Malignancies, Solid Tumors, Residual Leukemia, Hematopoietic Stem Cell Transplantation, Engineered T Cell Therapy, Automimmune Disorders, Infectious Diseases, Multiplexed Therapy, Oncology, Immune System, Therapeutic Platforms, Life Sciences Innovation |
| Website | ||
| Website | kyvernatx.com | tscan.com |
About Kyverna Therapeutics
Kyverna Therapeutics, founded in 2018, is a United States-based clinical-stage biopharmaceutical company that aims to revolutionize treatment for autoimmune diseases by leveraging cell therapy. Their slogan, "Harnessing the power of cell therapy in autoimmune disease," highlights their focus on prov...
About TScan Therapeutics
TScan Therapeutics, founded in 2018 and headquartered in the United States, specializes in pioneering T cell therapies aimed at tapping into the full potential of the human immune system. The company's slogan, "Unleash Immunity," reflects its dedication to developing life-changing therapeutics. Ren...
We will tell you when either one moves
BounceWatch watches Kyverna Therapeutics and TScan Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Kyverna Therapeutics and TScan Therapeutics — by email.
Frequently Asked Questions
Compare Kyverna Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Kyverna Therapeutics on 9 Jun 2026, and TScan Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
